# Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)

> **NCT06632470** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Baermed** · enrollment: 54 (estimated)

## Conditions studied

- Dementia
- Moderate Dementia

## Interventions

- **DRUG:** Secretome injection
- **DRUG:** Vitamin B12 Injection

## Key facts

- **NCT ID:** NCT06632470
- **Lead sponsor:** Baermed
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-10-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06632470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06632470, "Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06632470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*